Skip to main content
SpringerLink
Log in

Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Rats were sensitized by i. d. injection in the base of the tail with Freund's complete adjuvant (FCA) and were challenged i. d. in the dorsal skin with mycobacterial antigen. The 24 hour dermal delayed-type hypersensitivity (DTH) response increased up to 10 days after FCA injection followed by a decrease by day 15 which coincided with the development of adjuvant arthritis (AA). Drug studies were performed, using a 4-day dosing schedule, on optimal DTH elicited on day 10, suboptimal DTH elicited on day 15, and AA (day 16). Cyclosporine, leflunomide and prednisolone significantly inhibited day 10 DTH and AA with no effect on day 15 DTH. Indomethacin and tiaprofenic acid significantly inhibited AA with no effect on either DTH response. Chloroquine, levamisole,d-penicillamine, diazepam and RU38468 had no significant effect on DTH or AA. These findings suggest a complex temporal relationship between AA, DTH and drug actions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. J. Perper, A. L. Oronsky and V. Blancuzzi,Antibody to mycobacterial antigens in adjuvant arthritis (AA) 1. Relationship to disease and delayed hypersensitivity. Arthritis Rheum.15, 283–292 (1972).

    PubMed  Google Scholar 

  2. K. R. Gans, S. Heyner and R. F. Orzechowski,Application of a radiometric ear assay for studies of adjuvant arthritis in rats. Arthritis Rheum.23, 633–640 (1980).

    PubMed  Google Scholar 

  3. F. B. De Brito, A. R. Moore, D. G. Corry and D. A. Willoughby,A time course study of the changes that occur to the subcutaneous model of synovium following polyarthritogen. Br. J. exp. Path.68, 559–567 (1987).

    Google Scholar 

  4. L. Kourounakis, M. A. Kapusta and M. Young-Rodenchuk,Restoration of diminished splenic responses to phytohemagglutin and concanavalin A in adjuvant-induced disease by corticosteroids. J. Rheumatol.6, 497–506 (1979).

    PubMed  Google Scholar 

  5. S. C. Gilman, J. F. Daniels, R. E. Wilson, R. P. Carlson and A. J. Lewis,Lymphoid abnormalities in rats with adjuvant-induced arthritis-I. Mitogen responsiveness and lymphokine synthesis. Ann. Rheum. Dis.43, 847–855 (1984).

    PubMed  Google Scholar 

  6. L. Binderup, E. Bramm and E. Arrigoni-Martelli,The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation. Int. J. Immunopharmac.4, 57–66 (1982).

    Article  Google Scholar 

  7. S. C. Gilman, R. P. Carlson, J. F. Daniels, L. Datko, P. R. Berner, J. Chang and A. J. Lewis,Immunological abnormalities in rats with adjuvant-induced arthritis-II. Effect of antiarthritic therapy on immune function in relation to disease development. Int. J. Immunopharmac.9, 9–16 (1987).

    Article  Google Scholar 

  8. R. R. Bartlett and R. Schleyerbach,Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity—I. Disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharmac.7, 7–18 (1985).

    Article  Google Scholar 

  9. R. D. Pasternak, N. S. Wadopian, R. N. Wright, P. Siminoff, J. A. Gylys and J. P. Buyniski,Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis. Agents and Actions21, 241–243 (1987).

    Article  PubMed  Google Scholar 

  10. B. H. Waksman, C. M. Pearson and J. T. Sharp,Studies of arthritis and other lesions induced in rats by injection of mycobacterial antigen—II. Evidence that the disease is a disseminated immunologica response to exogenous antigen. J. Immunol.85, 403–417 (1960).

    PubMed  Google Scholar 

  11. O. Koyashi, A. Tanaka, S. Kotani, T. Shiba, S. Kusumoto, K. Yokogawa, S. Kawata and A. Ozawa,Arthritis-inducing ability of a synthetic adjuvant, N-acetyl muramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition. Infect. Immunol.99, 70–75 (1980).

    Google Scholar 

  12. Y. H. Chang, C. M. Pearson and C. Abe,Adjuvant polyarthritis-IV. Induction by a synthetic adjuvant: immunologic, histopathologic and other studies. Arthritis Rheum.23, 62–71 (1980).

    PubMed  Google Scholar 

  13. W. Van Eden, J. Holoshitz, Z. Nevo, A. Frenkel, A. Klajman and I. R. Cohen,Arthritis induced by a T-lymphocyte clone that response to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. USA82, 5117–5120 (1985).

    PubMed  Google Scholar 

  14. R. F. Van Vollenhoven, A. Soriano, P. E. McCarthy, R. L. Schwartz, F. C. Garbrecht, J. Thorbecke and G. W. Siskind,The role of immunity to cartilage proteoglycan in adjuvant arthritis. J. Immunol.141, 1168–1173 (1988).

    PubMed  Google Scholar 

  15. A. R. Mackenzie, C. R. Pick, P. R. Sibley and B. P. White,Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease. Clin. exp. Immunol.32, 86–96 (1978).

    PubMed  Google Scholar 

  16. W. J. Johnson, K. A. Muirhead, P. C. Meunier, B. J. Votta, T. C. Schmitt, M. J. DiMartino and N. Hanna,Macrophage activation in rat models of inflammation and arthritis. Arthritis Rheum.29, 1122–1130 (1986).

    PubMed  Google Scholar 

  17. E. Bramm, L. Binderup and E. Arrigoni-Martelli,An unusual profile of activity of a new basic anti-inflammatory drug, timegadine. Agents and Actions11, 402–409 (1981).

    PubMed  Google Scholar 

  18. M. J. DiMartino, D. E. Griswold, B. A. Berkowitz, G. Poste and N. Hanna,Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase. Agents and Actions20, 113–123 (1987).

    PubMed  Google Scholar 

  19. F. J. Beck and M. W. Whitehouse,Effect of adjuvant disease on cyclophosphamide and isophosphamide metabolism. Biochem. Pharmacol.22, 2453–2468 (1973).

    Article  PubMed  Google Scholar 

  20. P. Hambleton and S. McMahon,Differential drug actions on oedema formation and leukocyte accumulation in rat immunological inflammation. Br. J. Pharmacol.96, 171 P (1989).

    Google Scholar 

  21. M. E. J. Billingham,Models of arthritis and the search for anti-arthritic drugs. Pharmac. Ther.21, 389–428 (1983).

    Article  Google Scholar 

  22. E. Bramm, L. Binderup and E. Arrigoni-Martelli,Delayed hypersensitivity to tuberculin in rats: Effects of antirheumatic drugs. Acta pharmacol. et toxicol.44, 75–80 (1979).

    Google Scholar 

  23. S. M. Barlow, A. F. Knight and F. M. Sullivan,Plasma corticosterone responses to stress following chronic oral administration of diazepam in the rat. J. Pharm. Pharmacol.31, 23–26 (1979).

    PubMed  Google Scholar 

  24. C. Bolton and R. J. Flower,The effects of the anti-glucocorticoid RU38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci.45, 97–104 (1989).

    Article  PubMed  Google Scholar 

  25. R. Dantzer and K. W. Kelley,Stress and Immunity: an integrated view of relationships between the brain and the immune system. Life Sci.44, 1995–2008 (1989).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kingfisher Drive, Roussel Laboratories Limited, Covingham, SN3 5BZ, Swindon, Wiltshire, UK

    P. Hambleton & S. McMahon

Authors
  1. P. Hambleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hambleton, P., McMahon, S. Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis. Agents and Actions 29, 328–332 (1990). https://doi.org/10.1007/BF01966465

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966465

Keywords

Search

Navigation